These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31207262)

  • 21. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
    Jardin BA; Montes J; Lanthier S; Tran R; Elias C
    Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving bioreactor production of a recombinant glycoprotein in Escherichia coli: Effect of specific growth rate on protein glycosylation and specific productivity.
    Caillava AJ; Ortiz GE; Melli LJ; Ugalde JE; Ciocchini AE; Comerci DJ
    Biotechnol Bioeng; 2019 Jun; 116(6):1427-1438. PubMed ID: 30739323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shift to high-intensity, low-volume perfusion cell culture enabling a continuous, integrated bioprocess.
    Gagnon M; Nagre S; Wang W; Hiller GW
    Biotechnol Prog; 2018 Nov; 34(6):1472-1481. PubMed ID: 30298995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing.
    Matanguihan C; Wu P
    Curr Opin Biotechnol; 2022 Dec; 78():102828. PubMed ID: 36332340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing.
    Ito T; Wang H; Hwang SH; Wang B; Wang L; G S
    Biologicals; 2023 Nov; 84():101713. PubMed ID: 37793309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Tubespins as a suitable scale-down model of bioreactors for high cell density CHO cell culture.
    Gomez N; Ambhaikar M; Zhang L; Huang CJ; Barkhordarian H; Lull J; Gutierrez C
    Biotechnol Prog; 2017 Mar; 33(2):490-499. PubMed ID: 27977914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant reduction of lactate and ammonia accumulation in fed-batch cultures: Impact on glycoprotein production and quality.
    Karengera E; Robotham A; Kelly J; Durocher Y; De Crescenzo G; Henry O
    Biotechnol Prog; 2018 Mar; 34(2):494-504. PubMed ID: 29314777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of human cell line, F2N78, for the production of recombinant antibody in fed-batch and perfusion cultures.
    Seo JS; Min BS; Kwon YB; Lee SY; Cho JM; Park KH; Yang YJ; Maeng KE; Chang SJ; Kim DI
    J Biosci Bioeng; 2016 Mar; 121(3):317-24. PubMed ID: 26454770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fed-Batch CHO Cell Culture for Lab-Scale Antibody Production.
    Fan Y; Ley D; Andersen MR
    Methods Mol Biol; 2018; 1674():147-161. PubMed ID: 28921435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.
    Sinharoy P; Aziz AH; Majewska NI; Ahuja S; Handlogten MW
    Sci Rep; 2020 Oct; 10(1):16620. PubMed ID: 33024175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed-batch systems.
    Rouiller Y; Bielser JM; Brühlmann D; Jordan M; Broly H; Stettler M
    Biotechnol Prog; 2016; 32(1):160-70. PubMed ID: 26489036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid intensification of an established CHO cell fed-batch process.
    Schulze M; Niemann J; Wijffels RH; Matuszczyk J; Martens DE
    Biotechnol Prog; 2022 Jan; 38(1):e3213. PubMed ID: 34542245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
    Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
    Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega-3 production by fermentation of Yarrowia lipolytica: From fed-batch to continuous.
    Xie D; Miller E; Sharpe P; Jackson E; Zhu Q
    Biotechnol Bioeng; 2017 Apr; 114(4):798-812. PubMed ID: 27861744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of dissolved oxygen-controlled, fed-batch aerobic cultivation for recombinant protein subunit vaccine manufacturing.
    Farrell P; Sun J; Champagne PP; Lau H; Gao M; Sun H; Zeiser A; D'Amore T
    Vaccine; 2015 Nov; 33(48):6752-6. PubMed ID: 26518402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A system identification approach for developing model predictive controllers of antibody quality attributes in cell culture processes.
    Downey B; Schmitt J; Beller J; Russell B; Quach A; Hermann E; Lyon D; Breit J
    Biotechnol Prog; 2017 Nov; 33(6):1647-1661. PubMed ID: 28786215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process performance and product quality in an integrated continuous antibody production process.
    Karst DJ; Steinebach F; Soos M; Morbidelli M
    Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.